Cite
HARVARD Citation
Bálint, A. et al. (2018). Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis – results from multicenter observational cohort. Expert opinion on biological therapy. pp. 1181-1187. [Online].